Sanjay Shukla is President and CEO of aTYR PHARMA INC. Currently has a direct ownership of 136,548 shares of LIFE, which is worth approximately $253,979. The most recent transaction as insider was on May 31, 2024, when has been sold 20,000 shares (Common Stock) at a price of $1.81 per share, resulting in proceeds of $36,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K
0% 3M change
28.61% 12M change
Total Value Held $253,979

Sanjay Shukla Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2024
BUY
Open market or private purchase
$36,200 $1.81 p/Share
20,000 Added 12.78%
136,548 Common Stock
Feb 05 2024
BUY
Exercise of conversion of derivative security
-
10,375 Added 8.17%
116,548 Common Stock
Dec 12 2023
BUY
Open market or private purchase
$14,160 $1.18 p/Share
12,000 Added 10.15%
106,173 Common Stock
Dec 11 2023
BUY
Open market or private purchase
$3,510 $1.17 p/Share
3,000 Added 3.09%
94,173 Common Stock
Nov 13 2023
BUY
Open market or private purchase
$15,071 $1.11 p/Share
13,578 Added 12.96%
91,173 Common Stock
Nov 10 2023
BUY
Open market or private purchase
$1,621 $1.14 p/Share
1,422 Added 1.8%
77,595 Common Stock
Jul 28 2023
BUY
Open market or private purchase
$30,149 $2.01 p/Share
15,000 Added 16.45%
76,173 Common Stock
Feb 03 2023
BUY
Exercise of conversion of derivative security
-
10,375 Added 14.5%
61,173 Common Stock
Nov 21 2022
BUY
Open market or private purchase
$21,400 $2.14 p/Share
10,000 Added 16.45%
50,798 Common Stock
Jul 01 2022
BUY
Open market or private purchase
$43,200 $2.88 p/Share
15,000 Added 26.88%
40,798 Common Stock
Jan 07 2022
BUY
Open market or private purchase
$33,800 $6.76 p/Share
5,000 Added 16.23%
25,798 Common Stock
Nov 15 2021
BUY
Open market or private purchase
$21,425 $8.57 p/Share
2,500 Added 10.73%
20,798 Common Stock
May 18 2021
BUY
Open market or private purchase
$40,100 $4.01 p/Share
10,000 Added 35.34%
18,298 Common Stock
Feb 09 2021
SELL
Open market or private sale
$5,959 $7.66 p/Share
778 Reduced 8.57%
8,298 Common Stock
Feb 06 2021
BUY
Exercise of conversion of derivative security
-
1,785 Added 16.43%
9,076 Common Stock
SS

Sanjay Shukla

President and CEO
San Diego, CA

Track Institutional and Insider Activities on LIFE

Follow aTYR PHARMA INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LIFE shares.

Notify only if

Insider Trading

Get notified when an A Tyr Pharma Inc insider buys or sells LIFE shares.

Notify only if

News

Receive news related to aTYR PHARMA INC

Track Activities on LIFE